[Form 4] FormFactor Inc. Insider Trading Activity

Rhea-AI Filing Summary

Rebeca Obregon-Jimenez, a director of FormFactor Inc. (FORM), reported a sale of 4,000 common shares on 08/13/2025 at $29.5506 per share. After the transaction she beneficially owned 13,126 shares. The Form 4 was submitted by her attorney-in-fact, Stan Finkelstein. No derivative securities were reported in the filing.

Positive

• Director retains 13,126 shares after the sale, demonstrating continued direct ownership in the company
• No derivative transactions were reported, simplifying the disclosure to a straightforward non-derivative sale

Negative

• Director sold 4,000 shares, reducing direct insider holdings
• Sale recorded at $29.5506 per share, which may be interpreted by some investors as disposition activity

Insights

Financial Analyst

TL;DR: Insider sold a small block of shares; ownership remains post-sale and no derivatives were reported.

The reported disposition of 4,000 shares at $29.5506 reduces the director's direct holdings to 13,126 shares. The filing includes only non-derivative activity and shows the transaction as a sale code. Based solely on the filing, this appears to be a routine insider sale with neutral immediate financial implications.

Corporate Governance Expert

TL;DR: Director transaction disclosed and executed via attorney-in-fact; no other governance changes disclosed.

The Form 4 documents a direct sale by a director and identifies an attorney-in-fact as the filing signatory. There are no reported option exercises, grants, or changes in control. From a governance perspective, the filing is a standard disclosure of insider selling activity without additional corporate actions or changes to board composition.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Obregon-Jimenez Rebeca

(Last) (First) (Middle)

7005 SOUTHFRONT ROAD

(Street)

LIVERMORE CA 94551

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FORMFACTOR INC [ FORM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		S		4,000	D	$29.5506	13,126	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stan Finkelstein, Attorney-in-fact for Rebeca Obregon-Jimenez	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did FormFactor (FORM) insider Rebeca Obregon-Jimenez report?

She reported a sale of 4,000 common shares on 08/13/2025 at $29.5506 per share, leaving 13,126 shares beneficially owned.

How many shares did the director sell and at what price?

The filing shows a sale of 4,000 shares at a price of $29.5506 per share.

What is Rebeca Obregon-Jimenez's relationship to FORM?

The filing identifies Rebeca Obregon-Jimenez as a Director of FormFactor Inc.

Were any derivative securities reported in this Form 4 for FORM?

No derivative securities were reported; Table II is empty and only non-derivative common stock activity appears.

Who signed the Form 4 filed for this transaction?

The Form 4 was signed by Stan Finkelstein, Attorney-in-fact for Rebeca Obregon-Jimenez.